Reata Pharmaceuticals Inc. Class A (RETA) Financials

$172.36

$0.00 (0.00%)

As on 26-Sep-2023 09:30EDT

Market cap

$6,566 Mln

Revenue (TTM)

$24 Mln

P/E Ratio

--

P/B Ratio

285.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	24.40	2.22	11.49	9.02	26.52	53.59
Cost of Revenue	0.85	--	--	--	124.40	97.29
Gross Profit	23.55	2.22	11.49	9.02	-97.88	53.59
Operating Expenses	364.30	280.25	256.20	235.34	187.34	130.47
Operating Profit (EBIT)	-59.48	-270.16	-244.71	-226.33	-285.22	-76.88
Other Income	-20.21	-33.89	-53.13	-43.91	-4.94	2.53
Profit before Tax	-87.68	-311.93	-297.84	-270.24	-290.16	-80.52
Provision for Tax	0.25	-0.03	-0.45	-22.49	0.01	0.03
Profit after Tax (Net Income)	-80.06	-311.90	-297.39	-247.75	-290.17	-80.55
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-280.62	-311.90	-297.39	-247.75	-290.17	-80.55

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	87.29	-65.70	-1,255.63	-958.25	-710.49	-420.32
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	290.20	521.23	495.03	320.97	233.55	274.13
Current Liabilities	125.09	58.96	53.99	119.20	192.01	55.92
Total Liabilities	627.68	514.49	735.02	857.60	682.42	345.21

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	100.74	116.72	138.54	10.26	13.14	2.94
Current Assets	401.85	397.77	596.48	847.34	669.28	342.27
Total Assets	627.68	514.49	-706.60	-518.08	-284.93	-90.27
Total Debt*	166.00	119.46	136.03	--	395.65	94.64
Net Current Assets	276.76	338.81	542.48	728.14	477.26	286.35

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-204.27	-235.70	-322.34	-251.15	-83.78
Cash Flow from Investing Activities	--	-345.16	-1.33	-0.93	-2.67	-0.68
Cash from Financing Activities	--	1.49	9.14	477.09	580.36	292.47
Net Cash Inflow / Outflow	--	-547.95	-227.89	153.83	326.53	208.01

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-2.80	-8.59	-8.17	-7.16	-9.17	-2.71
Cash EPS ($)	--	-8.56	-8.14	-7.12	-9.14	-2.70
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-5.62	-6.48	-9.31	-7.94	-2.82
Free Cash Flow per Share ($)	--	-5.71	-6.51	-9.34	-8.02	-2.84

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	58.53	28.62	38.92	90.60	35.56
ROE (%)	--	47.21	26.87	29.69	51.32	28.40
ROA (%)	-12.26	-49.92	-37.35	-32.18	-56.47	-33.52
EBIT Margin (%)	-1,368.23	-12,191.11	-2,129.75	-2,509.42	-1,075.61	-143.46
Net Margin (%)	-1,913.41	984.66	714.22	709.99	-1,344.94	-143.52
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	143.93	-0.81	0.27	-0.66	-0.51	0.12
EBIT Growth (%)	-29.51	-10.40	-8.12	20.65	-271.00	-63.87
Net Profit Growth (%)	73.72	-4.88	-20.03	14.62	-260.25	-68.96
EPS Growth (%)	66.48	-0.05	-0.14	0.22	-2.38	-0.49
Book Value Growth (%)	105.47	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-4.42	-3.23	-17.28	-22.28	-20.70
Price / Book Value	285.94	-21.00	-0.76	-4.47	-9.10	-3.97
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.75	-4.13	-2.08	-15.38	-21.80	-18.63
Close Price ($)	101.96	37.99	26.37	123.62	204.43	56.10
High Price ($)	106.69	43.90	153.41	257.97	224.02	99.50
Low Price ($)	18.47	18.47	25.02	88.17	51.77	19.31
Market Cap ($ Cr)	6,566.45	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.84	-1.82	-0.11	--	-0.56	-0.23
Short term debt to equity ratio	0.03	-0.03	0.00	-0.09	-0.24	-0.04
Current Ratio	3.21	6.75	11.05	7.11	3.49	6.12
Quick Ratio	3.19	--	--	7.29	--	--
Interest Coverage	-1.16	-6.47	-4.60	-6.15	-25.47	-12.45

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	92.90	--	--	246.46	--	--
Asset Turnover	0.04	0.00	0.01	0.01	0.05	0.22
Receivable days	--	--	706.60	900.19	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	9.37	12.28
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.